Evidence map›Paper›PMID 38997532›Full record

ArticleJournal of general internal medicine2024

Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MA.

Ranjani K Paradise, Angela R Bazzi, Jaylen Clarke, Jeffrey Desmarais, Andres Hoyos-Cespedes, Alykhan Nurani, Shannon E O'Malley, Sunday Taylor, Alexander Y Walley, Daniel Dooley and 1 more

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ranjani K ParadiseInstitute for Community Health, Malden, MA, USA. rparadise@icommunityhealth.org.ORCID 0009-0002-6385-9384
Angela R BazziUniversity of California, San Diego, La Jolla, CA, USA.
Jaylen ClarkeBoston Public Health Commission, Boston, MA, USA.
Jeffrey DesmaraisInstitute for Community Health, Malden, MA, USA.
Andres Hoyos-CespedesInstitute for Community Health, Malden, MA, USA.
Alykhan NuraniBoston Medical Center, Boston, MA, USA.
Shannon E O'MalleyBoston Public Health Commission, Boston, MA, USA.
Sunday TaylorBoston Public Health Commission, Boston, MA, USA.
Alexander Y WalleyBoston Medical Center, Boston, MA, USA.
Daniel DooleyBoston Public Health Commission, Boston, MA, USA.
Simeon D KimmelBoston Medical Center, Boston, MA, USA.

Funding

Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)K23DA054363 · NIDA · BOSTON MEDICAL CENTER · PI KIMMEL, SIMEON · 2021 to 2025
$947k
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
NIDA NIH HHS K01 DA043412NIDA NIH HHS K23 DA054363NIDA NIH HHS K23DA054363NIH HHS K01DA043412
6 · The paper itself

Abstract

backgroundThere are well-documented racial/ethnic inequities in drug-related overdoses and access to evidence-based opioid use services nationally and in Boston, MA.

objectiveTo qualitatively explore the drivers of racial/ethnic inequities in access to opioid use disorder treatment and services in Boston.

designSemi-structured qualitative interviews.

participantsUsing purposive sampling, researchers recruited 59 opioid overdose survivors in Boston who self-identified as Black, Hispanic or Latino/a/x, and/or White. APPROACH: Interviewers administered a socio-demographic and drug use survey, and used a semi-structured interview guide to explore experiences with and perspectives on substance use treatment and services. KEY

resultsParticipants' racial/ethnic identities were distributed across three subgroups: non-Hispanic Black (n = 18; 31%), non-Hispanic White (n = 18; 31%), and Latino/a/x (n = 23; 39%). Qualitative analysis identified multiple themes that were organized into four social-ecological levels after analysis. At the individual level, some participants emphasized the importance of personal responsibility and individual motivation in determining access to services. Participants expressed a range of perspectives about using medication for opioid use disorder treatment; Black and Latino/a/x participants were more likely than White participants to have critical perspectives. At the interpersonal level, experiences of bias, stigma, and racism from staff in healthcare and treatment settings were common. At the program/process level, participants described challenges connecting to services following overdose and barriers within specific programs, with Black and Latino/a/x participants experiencing particular gaps. At the systems level, the limited availability of housing, employment, and mental health care negatively impacted treatment access and engagement.

conclusionA racism lens was used during data interpretation to apply the themes at a broader population level. Through this lens, the identified barriers can be understood to have a disproportionate impact on people of color. Findings call for programmatic and policy solutions that address racism, break down stigma, and ensure equitable access to evidence-based services and social supports.

Indexed as

Healthcare DisparitiesHealth Services AccessibilityOpiate OverdoseAdultBlack or African AmericanBostonFemaleHispanic or LatinoHumansMaleMiddle AgedOpioid-Related DisordersQualitative ResearchWhiteharm reductionopioid use disorderoverdoseracial equitysubstance use treatment

Identifiers

PMID38997532
PMCPMC11436504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.